Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CIDMNYSE:HHSOTCMKTS:MMNDOTCMKTS:PBSV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIDMCinedigm$4.80+14.8%$1.54$0.27▼$0.79$897.19M2.05710,288 shs3.34 million shsHHSHarte Hanks$4.15-17.8%$2.70$3.24▼$8.87$37.83M0.7223,941 shs15,684 shsMMNDMastermind$0.03$0.03$0.02▼$0.09$1.04M-0.3914,837 shsN/APBSVPharma-Bio Serv$0.51-15.0%$0.48$0.31▼$0.67$11.69M0.686,499 shs5,000 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIDMCinedigm0.00%+23.39%+34.27%+47.69%+439.33%HHSHarte Hanks0.00%+2.76%-9.70%-15.74%-49.57%MMNDMastermind0.00%+7.14%-6.54%-35.76%-25.00%PBSVPharma-Bio Serv0.00%0.00%+2.00%+2.00%-21.30%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCIDMCinedigmN/AN/AN/AN/AN/AN/AN/AN/AHHSHarte Hanks0.4619 of 5 stars0.05.00.00.00.60.80.0MMNDMastermindN/AN/AN/AN/AN/AN/AN/AN/APBSVPharma-Bio Serv0.392 of 5 stars0.03.00.00.01.00.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCIDMCinedigm 0.00N/AN/AN/AHHSHarte Hanks 0.00N/AN/AN/AMMNDMastermind 0.00N/AN/AN/APBSVPharma-Bio Serv 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCIDMCinedigm$72.33M12.40N/AN/AN/A∞HHSHarte Hanks$191.49M0.16$0.79 per share5.23$2.75 per share1.51MMNDMastermind$4.71M0.22N/AN/AN/A∞PBSVPharma-Bio Serv$9.51M1.23N/AN/A$0.60 per share0.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCIDMCinedigmN/A-$0.05N/A∞N/AN/AN/AN/AN/AHHSHarte Hanks-$1.57M-$4.05N/A∞N/A-15.91%32.07%5.75%N/AMMNDMastermindN/AN/A0.00∞N/AN/A-4.45%-3.75%8/12/2025 (Estimated)PBSVPharma-Bio Serv-$780K-$0.01N/A∞N/A-1.96%-1.47%-1.21%9/15/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCIDMCinedigmN/AN/AN/AN/AN/AHHSHarte HanksN/AN/AN/AN/AN/AMMNDMastermindN/AN/AN/AN/AN/APBSVPharma-Bio ServN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCIDMCinedigmN/AN/AN/AHHSHarte HanksN/A1.461.46MMNDMastermindN/AN/AN/APBSVPharma-Bio ServN/A7.547.54Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCIDMCinedigm8.03%HHSHarte Hanks33.75%MMNDMastermindN/APBSVPharma-Bio ServN/AInsider OwnershipCompanyInsider OwnershipCIDMCinedigm16.40%HHSHarte Hanks12.28%MMNDMastermindN/APBSVPharma-Bio Serv12.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCIDMCinedigm140186.92 millionN/ANot OptionableHHSHarte Hanks1,9627.29 million6.39 millionNot OptionableMMNDMastermind2834.51 millionN/ANot OptionablePBSVPharma-Bio Serv18522.93 million20.04 millionNot OptionableHHS, CIDM, MMND, and PBSV HeadlinesRecent News About These CompaniesPBSV Pharma-Bio Serv, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comOTC:PBSV Financials | Pharma-Bio Serv Inc - Investing.comJune 26, 2025 | investing.comPharma-Bio Serv (OTCMKTS:PBSV) and Gartner (NYSE:IT) Critical ReviewJune 26, 2025 | americanbankingnews.comPBSV Decisions Paying OffJune 19, 2025 | msn.comPharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025June 16, 2025 | accessnewswire.comAPBSV Returns to GrowthMarch 18, 2025 | msn.comPharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025March 17, 2025 | accessnewswire.comAPharma-Bio Serv Inc.: Pharma-Bio Serv Announces Full Year ResultsJanuary 31, 2025 | finanznachrichten.dePBSV Released Earnings and Declares DividendJanuary 30, 2025 | msn.comPharma-Bio Serv declares special dividend for shareholdersJanuary 30, 2025 | msn.comPharma-Bio Serv Announces Full Year ResultsJanuary 29, 2025 | accessnewswire.comAPharma-Bio Serv Announces Special DividendJanuary 29, 2025 | accessnewswire.comAScotiabank Initiates Coverage of BridgeBio Pharma (BBIO) with Sector Outperform RecommendationOctober 17, 2024 | msn.comBPGbio to Present on E2-based Approach to Targeted Protein Degradation at US Pharma Partnering SummitOctober 15, 2024 | standard-journal.comSBristol Myers, 2seventy bio halt enrollment in Abecma late-stage trialSeptember 25, 2024 | msn.comPBSV Makes Progress on ImprovementsSeptember 17, 2024 | msn.comPharma-Bio Serv Announces Results for the Quarter Ended July 31, 2024September 16, 2024 | accesswire.comASolving pharma’s patient services paradoxAugust 31, 2024 | pharmaphorum.comPVersant’s Jerel Davis on build-to-buy deals and pharma investmentAugust 28, 2024 | biopharmadive.comBPharma-Bio Serv Inc PBSVAugust 8, 2024 | morningstar.comMNew MarketBeat Followers Over TimeHHS, CIDM, MMND, and PBSV Company DescriptionsCinedigm NASDAQ:CIDMCineverse Corp. is a global streaming technology and entertainment company. It owns and operates streaming channels, all powered by its advanced, proprietary technology platform. The firm currently features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. It entertains consumers around the globe by providing premium feature films and television series, enthusiast streaming channels, and technology services to some media, retail, and technology companies. The company was founded by A. Dale Mayo on March 31, 2000 and is headquartered in New York, NY.Harte Hanks NYSE:HHSHarte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX.Mastermind OTCMKTS:MMND$0.03 0.00 (0.00%) As of 06/27/2025Mastermind, Inc., an involvement marketing service agency, designs, creates, and develops branding and marketing campaigns for corporate clients. Its programs cover various forms, such as creating and managing digital content, designing campaign Websites/landing pages, social media and viral campaigns, mobile marketing initiatives, and brand communications. The company customers comprise of sports and entertainment, oil and gas, automotive, retail, restaurant, B2B, financial services, hotel and hospitality, consumer packaged goods, healthcare and pharmaceuticals, technology, and agricultural chemicals. Mastermind, Inc. was founded in 2012 and is based in Atlanta, Georgia. Mastermind, Inc. is a subsidiary of Mastermind Marketing, Inc.Pharma-Bio Serv OTCMKTS:PBSV$0.51 -0.09 (-15.00%) As of 06/27/2025 09:30 AM EasternPharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
